vs
Side-by-side financial comparison of Community West Bancshares (CWBC) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $31.1M, roughly 1.2× LIFECORE BIOMEDICAL, INC. \DE\). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs -4.5%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $25.0K). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs -0.1%).
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CWBC vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $31.1M |
| Net Profit | — | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 40.0% | -9.9% |
| Net Margin | — | -32.1% |
| Revenue YoY | 11.6% | -4.5% |
| Net Profit YoY | — | -52.0% |
| EPS (diluted) | $0.58 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | — | ||
| Q3 25 | $37.9M | $31.1M | ||
| Q2 25 | $35.7M | — | ||
| Q1 25 | $34.8M | $35.2M | ||
| Q4 24 | $34.3M | $32.6M | ||
| Q3 24 | $31.3M | $24.7M | ||
| Q2 24 | $30.5M | — | ||
| Q1 24 | $20.7M | $35.7M |
| Q4 25 | — | — | ||
| Q3 25 | $10.9M | $-10.0M | ||
| Q2 25 | $7.8M | — | ||
| Q1 25 | $8.3M | $-14.8M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $3.4M | $-16.2M | ||
| Q2 24 | $-6.3M | — | ||
| Q1 24 | $3.7M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 40.0% | — | ||
| Q3 25 | 39.8% | -9.9% | ||
| Q2 25 | 30.2% | — | ||
| Q1 25 | 32.7% | -25.7% | ||
| Q4 24 | 31.0% | -6.0% | ||
| Q3 24 | 13.3% | -46.9% | ||
| Q2 24 | -25.9% | — | ||
| Q1 24 | 23.2% | -2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 28.7% | -32.1% | ||
| Q2 25 | 22.0% | — | ||
| Q1 25 | 23.8% | -42.0% | ||
| Q4 24 | — | -20.2% | ||
| Q3 24 | 10.8% | -65.7% | ||
| Q2 24 | -20.7% | — | ||
| Q1 24 | 17.8% | 43.8% |
| Q4 25 | $0.58 | — | ||
| Q3 25 | $0.57 | $-0.29 | ||
| Q2 25 | $0.41 | — | ||
| Q1 25 | $0.44 | $-0.47 | ||
| Q4 24 | $0.29 | $-0.25 | ||
| Q3 24 | $0.18 | $-0.53 | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $0.31 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $119.0M | $18.9M |
| Total DebtLower is stronger | $69.5M | $136.0M |
| Stockholders' EquityBook value | $409.6M | $-10.5M |
| Total Assets | $3.7B | $235.2M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.0M | — | ||
| Q3 25 | $121.6M | $18.9M | ||
| Q2 25 | $134.4M | — | ||
| Q1 25 | $148.4M | $5.4M | ||
| Q4 24 | $120.4M | $9.5M | ||
| Q3 24 | $149.0M | — | ||
| Q2 24 | $109.7M | — | ||
| Q1 24 | $61.0M | — |
| Q4 25 | $69.5M | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | $69.9M | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $409.6M | — | ||
| Q3 25 | $397.6M | $-10.5M | ||
| Q2 25 | $380.0M | — | ||
| Q1 25 | $372.2M | $2.2M | ||
| Q4 24 | $362.7M | $15.4M | ||
| Q3 24 | $363.5M | $-3.9M | ||
| Q2 24 | $350.2M | — | ||
| Q1 24 | $211.7M | $17.7M |
| Q4 25 | $3.7B | — | ||
| Q3 25 | $3.6B | $235.2M | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.6B | $237.7M | ||
| Q4 24 | $3.5B | $255.4M | ||
| Q3 24 | $3.5B | $246.8M | ||
| Q2 24 | $3.5B | — | ||
| Q1 24 | $2.4B | $246.2M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | 0.19× | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.1M | $1.8M |
| Free Cash FlowOCF − Capex | $43.6M | $25.0K |
| FCF MarginFCF / Revenue | 113.9% | 0.1% |
| Capex IntensityCapex / Revenue | 6.6% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $77.7M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.1M | — | ||
| Q3 25 | $13.2M | $1.8M | ||
| Q2 25 | $11.5M | — | ||
| Q1 25 | $11.1M | $1.2M | ||
| Q4 24 | $22.2M | $-6.1M | ||
| Q3 24 | $7.8M | $-613.0K | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $4.0M | $-1.4M |
| Q4 25 | $43.6M | — | ||
| Q3 25 | $12.8M | $25.0K | ||
| Q2 25 | $10.6M | — | ||
| Q1 25 | $10.8M | $-4.3M | ||
| Q4 24 | $17.2M | $-8.6M | ||
| Q3 24 | $5.2M | $-4.0M | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | $3.6M | $-7.8M |
| Q4 25 | 113.9% | — | ||
| Q3 25 | 33.7% | 0.1% | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 30.9% | -12.1% | ||
| Q4 24 | 50.0% | -26.3% | ||
| Q3 24 | 16.7% | -16.3% | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 17.3% | -21.8% |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 1.1% | 5.6% | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 0.9% | 15.5% | ||
| Q4 24 | 14.7% | 7.5% | ||
| Q3 24 | 8.1% | 13.9% | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.1% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.09× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CWBC
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
